2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.86+$0.02 (+1.95%)
Price as of Sep 11, 2026 7:32 PM EDT- $97.3MMarket Cap
- 68.65%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.86+$0.02 (+1.95%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.84 | ||
Change | +$0.02 (+2.51%) | ||
Open | $0.85 | ||
High | $0.85 | ||
Low | $0.83 | ||
Previous Close | $0.82 | ||
Volume | 312,325 | ||
30-Day Average Volume | 650,343 | ||
1-Week Change | -2.62% | ||
1-Month Change | 7.34% | ||
1-Year Change | 68.65% | ||
3-Year Change | -75.58% | ||
5-Year Change | -95.82% | ||
Fundamentals | |||
Shares Outstanding | 115.4M | ||
Total Assets | $60.8M | ||
Market Cap | $97.3M | ||
Enterprise Value | $92.4M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.4M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$7.4M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $45.9M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 54 | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | N/A | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue